Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation
In patients undergoing OHT and receiving empiric antimicrobial therapy, change from VPT to VC did not affect the incidence or severity of AKI, renal recovery, or infection rates.
Authors
- Elaine Park
- Rupak Mukherjee (ORCID: https://orcid.org/0000-0003-4093-2200)
- Ryan J. Tedford (ORCID: https://orcid.org/0000-0001-9045-7722)
- Blaithin A. McMahon (ORCID: https://orcid.org/0000-0001-8585-2787)
- Arman Kilic (ORCID: https://orcid.org/0000-0001-8112-8345)
- Courtney E. Harris (ORCID: https://orcid.org/0000-0003-4611-0670)
- Patrick Murray (ORCID: https://orcid.org/0000-0001-8516-1839)
- Syed M. Quadri (ORCID: https://orcid.org/0000-0002-6395-7542)
- Ashley Golbus (ORCID: https://orcid.org/0000-0002-0987-2142)
Institutions
- University College Dublin (IE)
- Medical University of South Carolina (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1111/ctr.70213
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Duke Cancer Institute